β-Defensin Strengthens Antimicrobial Peritoneal Mast Cell Response

被引:7
作者
Agier, Justyna [1 ]
Brzezinska-Blaszczyk, Ewa [1 ]
Rozalska, Sylwia [2 ]
Wiktorska, Magdalena [3 ]
Wawrocki, Sebastian [4 ]
Zelechowska, Paulina [1 ]
机构
[1] Med Univ Lodz, Fac Hlth Sci, Dept Expt Immunol, Lodz, Poland
[2] Univ Lodz, Fac Biol & Environm Protect, Dept Ind Microbiol & Biotechnol, Lodz, Poland
[3] Med Univ Lodz, Fac Hlth Sci, Dept Mol Cell Mech, Lodz, Poland
[4] Univ Lodz, Fac Biol & Environm Protect, Dept Immunol & Infect Biol, Lodz, Poland
关键词
PROSTAGLANDIN D-2 PRODUCTION; HISTAMINE-RELEASE; LL-37; INNATE; SKIN;
D O I
10.1155/2020/5230172
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mast cells (MCs) are engaged in the processes of host defense, primarily via the presence of receptors responsible for the detection of pathogen-associated molecular patterns (PAMPs). Since BDs are exclusively host defense molecules, and MCs can elicit the antimicrobial response, this study is aimed at determining whether BDs might be involved in MC pathogen defense. We found that defensin BD-2 significantly augments the mRNA and protein expression of Toll-like receptors (TLRs) and retinoic acid-inducible gene-I-like receptor (RLR) essential for the detection of viral molecules, i.e., TLR3, TLR7, TLR9, and RIG-I in mature tissue rat peritoneal MCs (PMCs). We established that BD-2 might stimulate PMCs to release proinflammatory and immunoregulatory mediators and to induce a migratory response. Presented data on IgE-coated PMC upon BD-2 treatment suggest that in the case of allergies, there is an enhanced MC immune response and cell influx to the site of the ongoing infection. In conclusion, our data highlight that BD-2 might strongly influence MC features and activity, mainly by strengthening their role in the inflammatory mechanisms and controlling the activity of cells participating in antimicrobial processes.
引用
收藏
页数:14
相关论文
共 40 条
[1]   Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteria [J].
Ageitos, J. M. ;
Sanchez-Perez, A. ;
Calo-Mata, P. ;
Villa, T. G. .
BIOCHEMICAL PHARMACOLOGY, 2017, 133 :117-138
[2]   The RLR/NLR expression and pro-inflammatory activity of tissue mast cells are regulated by cathelicidin LL-37 and defensin hBD-2 [J].
Agier, Justyna ;
Rozalska, Sylwia ;
Wiktorska, Magdalena ;
Zelechowska, Paulina ;
Pastwinska, Joanna ;
Brzezinska-Blaszczyk, Ewa .
SCIENTIFIC REPORTS, 2018, 8
[3]   An overview of mast cell pattern recognition receptors [J].
Agier, Justyna ;
Pastwinska, Joanna ;
Brzezinska-Blaszczyk, Ewa .
INFLAMMATION RESEARCH, 2018, 67 (09) :737-746
[4]   Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells [J].
Agier, Justyna ;
Brzezinska-Blaszczyk, Ewa ;
Zelechowska, Paulina ;
Wiktorska, Magdalena ;
Pietrzak, Jacek ;
Rozalska, Sylwia .
JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
[5]   Cathelicidins and defensins regulate mast cell antimicrobial activity [J].
Agier, Justyna ;
Brzezinska-Blaszczyk, Ewa .
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2016, 70 :618-636
[6]   Cathelicidin impact on inflammatory cells [J].
Agier, Justyna ;
Efenberger, Magdalena ;
Brzezinska-Blaszczyk, Ewa .
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 40 (02) :225-235
[7]  
Arimura Y, 2004, ANTICANCER RES, V24, P4051
[8]   Human-derived cathelicidin LL-37 directly activates mast cells to proinflammatory mediator synthesis and migratory response [J].
Babolewska, Edyta ;
Brzezinska-Blaszczyk, Ewa .
CELLULAR IMMUNOLOGY, 2015, 293 (02) :67-73
[9]   Cathelicidin rCRAMP stimulates rat mast cells to generate cysteinyl leukotrienes, synthesize TNF and migrate: involvement of PLC/A2, PI3K and MAPK signaling pathways [J].
Babolewska, Edyta ;
Pietrzak, Anna ;
Brzezinska-Blaszczyk, Ewa .
INTERNATIONAL IMMUNOLOGY, 2014, 26 (11) :637-646
[10]   Human cathelicidin LL-37 increases vascular permeability in the skin via mast cell activation, and phosphorylates MAP kinases p38 and ERK in mast cells [J].
Chen, XJ ;
Ikeda, S ;
Chen, XJ ;
Niyonsaba, F ;
Ushio, H ;
Okumura, K ;
Ogawa, H ;
Chen, XJ ;
Nagaoka, I ;
Okumura, K .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2006, 43 (01) :63-66